1. (valid email required)
 

cforms contact form by delicious:days

CRi Biomedical Imaging Systems Used by World’s Top Pharmaceutical Companies

February 23, 2010

Biotechnology Leader Provides Technology of Choice for Leading Pharmaceutical Industry Scientists

Woburn, Massachusetts – January 27, 2010

Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, announced that 18 out of the top 20 pharmaceutical companies worldwide are using CRi’s optical imaging systems. These top pharmaceutical companies, ranked by revenue by Med Ad News in September 2009, have chosen CRi systems for molecular-based drug development and research.

There is a growing consensus among scientists that fulfilling the promise of molecular medicine requires a shift from the study of single events to viewing complex biological systems in their entirety. CRi’s integrated imaging products provide researchers and clinicians with quantitative assessments of disease and drug response. This is accomplished by evaluating multiple markers simultaneously in intact tissue samples, at a cellular level or in living small animals. CRi’s solutions have received strong industry recognition for having a significant impact in translational and clinical research and applications.

“The acceptance of CRi solutions by the world’s leading pharmaceutical companies further establishes the trend for drug development efforts, particularly in areas such as oncology, to focus on developing targeted therapies for more molecularly defined patient populations,” said George Abe, chief executive officer at CRi. “Researchers realize the significant capabilities of CRi’s platform technology and the efficiency and productivity gains that they provide, along with the potential to translate into diagnostic applications.”

CRi’s diverse and applications-focused products have revolutionized fluorescence and brightfield microscopy, in vivo imaging and assisted reproductive technologies. Based on its proprietary technology, CRi systems enable researchers to better explore biological pathways in drug development and personalized medicine by bridging the gap between combinatorial chemistry, flow cytometry and morphological imaging.

About CRi

Cambridge Research & Instrumentation, Inc. (CRi) develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented systems enable researchers and clinicians to quantitate multiple disease and drug response markers in intact tissue samples, at a cellular level or in living small animals. CRi’s products integrate a unique multispectral imaging technology with proprietary image analysis algorithms to achieve unparalleled accuracy and sensitivity, rapidly and cost-effectively. CRi’s award-winning systems include Nuance™ for multispectral imaging on brightfield and fluorescence microscopes; inForm™ automated image analysis software; Vectra™ for high-throughput slide imaging and analysis; and Maestro™ for in-vivo optical imaging. Learn more at www.cri-inc.com.

For more information, contact:

Cambridge Research & Instrumentation, Inc. (CRi)

Cathy Boutin, 781-935-9099

Marketing Manager

cboutin@cri-inc.com

or

Commonwealth Creative Associates

Jamie Bull, 508-620-0791

Digital Media Strategist

jamieb@commcreative.com

or

Commonwealth Creative Associates

Donna Phelps, 508-620-0791

Senior Account Executive

donnap@commcreative.com

Latest News

NWN named to CRN’s 2015 TE250 list

Amerigroup-Curaspan Pilot Findings Result in 12-Month Extension. Increased enrollment in community health programs spurs inclusion of Maryland HIE.

BCD and Zend Become Industry’s Primary Resource for PHP-on-IBM i Development Through Expanded Partnership. Industry leaders will tightly integrate to help IBM i organizations succeed at all stages of the PHP development lifecycle

Pic Nix Wins Best of Show – Allen & Gerritsen Takes Home the Top Prize at the Philadelphia Addy Awards with BEST OF SHOW

CYBEX UNVEILS NEW STRENGTH, CARDIO AND SERVICE SOLUTIONS AT IHRSA 2015

Datawatch Named to KMWorld Magazine’s “100 Companies That Matter in Knowledge Management” for Four Years Running

Aquent And Vitamin T Win Inavero’s 2015 Best of Staffing® AwardGlobal Creative Staffing Firm Once Again Recognized for Superior Client Service and Exceptional Job Candidate Experience

Bigbelly Honored as This Year’s Top Smart City Application. Receives People’s Choice Award in the 2014/15 Internet of Things Awards


Latest Newsletters

September Newsletter 2014

Mass. Capital Announces Addition to Investment Team

January 2014 Newsletter

December 2013 Newsletter

October 2013 Newsletter

June 2013 Newsletter

March 2013 Newsletter

Mass. Capital Announces Leadership Transition


Archives